SubHero Banner
Text

Briviact® (brivaracetam) – Expanded indication

May 14, 2018 - UCB announced the FDA approval of Briviact (brivaracetam) tablets and oral solution, for the treatment of partial-onset seizures in patients 4 years of age and older.

Download PDF